Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
about
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACAHigh-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with humIn vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library searchQuantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS.First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometryData on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegansIn Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22.Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry.Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18.In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.Oral fluid drug analysis in the age of new psychoactive substances.Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.Analysis of Parent Synthetic Cannabinoids in Blood and Urinary Metabolites by Liquid Chromatography Tandem Mass Spectrometry.Determination of AM-2201 metabolites in urine and comparison with JWH-018 abuse.Analysis of AM-2201 and metabolites in a drugs and driving case.Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry.In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014.In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry.
P2860
Q28540537-2EA1CC0D-1D8D-4C02-B6C8-4AE80F4713E0Q30244676-397598B0-24BC-4F37-8610-16FBF097B617Q33162567-7EEBFDFB-ABC8-4517-B171-CB05A23EBD2FQ33908169-298E2B1A-0B0B-46C2-AA54-BD0ACA8CAE0DQ34156299-FD9A6283-25A2-44D8-8BFE-D8C4BD070506Q34419089-CA660732-569E-431E-B375-1FB7838579A8Q34464722-6E392502-C926-497C-8363-1B10F303AF52Q34493135-75996614-0418-474D-90FE-65B2A923F2DBQ34501432-AC58E4C8-93C7-40B5-B6C3-229E983FA5A1Q34514221-C90105C2-9579-42E7-83B1-BE2A3B1F6FACQ34553148-18D9CE23-F07C-4DDE-8F6B-F79CF56391AAQ34607414-832DD9DD-0292-4A1A-A3E3-771778977DA5Q35187100-5172673C-CC42-4A28-BC6A-61540CEE7FC0Q35254099-B34EF092-ED5F-40EF-BD83-4780D4A101D5Q35748441-324A9E37-FE1A-4681-BF27-C9F8637AF05EQ35956991-04B090E7-3F2D-4E48-AD21-B7CCF88013A3Q35957128-3C6B9F8C-7BBD-450B-B923-F5DD349210DBQ36653901-FEB5A3AF-70F8-4C27-942A-262565DCB0F8Q36950560-96BC662B-DF17-4941-B906-7387BA603DADQ37207836-52703953-2333-4639-A3E5-7C7C42607301Q37397048-AE7B28A4-4F69-4799-A15C-3F14C6DAC437Q38411456-49151DE5-7229-437D-BB52-F5B7553F6920Q38611708-27C0A81F-2320-4AD7-A53E-95621D56F690Q38616637-215A97D5-C6F1-402B-AEBA-F5D7814AD163Q38768825-30833DC4-D8EF-4C65-8C77-FF42A70EE9C6Q39052265-8276F716-D00E-4247-8B98-5796487A2EBDQ42751412-5F4C4DBC-F7E3-4084-9004-8C9067EE2903Q43641739-23916F0B-1C53-4FEE-A92C-1273B617726AQ45066806-3988CD61-0AD5-411B-A8A9-2F93FB619CCEQ45898212-2F420FF8-3140-491B-AE80-305CBDA27F14Q46594306-6924611E-086A-4A93-9C41-EFF5A7C90ACFQ46809828-B160B0B6-5BA8-49AE-AD0A-7C5A9BC57A54Q47854801-45A757FF-0F7D-498A-A62A-6631D924D9A7Q48220900-1322819B-D374-420B-B8A5-C2C97F1D5336Q49227467-9DC96D6A-8B8A-4D37-AF49-0D67FB182018Q50277873-B4C0941A-1B7E-4B65-B81F-698DB763E4A9Q52887320-BDCCD3BA-F4FD-4DCD-B747-6441B62E7929Q53255318-92487AD6-F366-4C67-B0AD-EBAAA68A2525Q53546061-5588C033-2368-4007-B065-78C0B11E83A7Q55386497-E78C1177-2684-4B0D-B493-5C73F21D07D0
P2860
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@ast
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@en
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@nl
type
label
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@ast
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@en
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@nl
prefLabel
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@ast
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@en
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@nl
P2093
P2860
P356
P1476
Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
@en
P2093
Grigory Rodchenkov
Ilya Prasolov
Tim Sobolevsky
P2860
P304
P356
10.1002/DTA.1418
P577
2012-10-05T00:00:00Z